OECDReference EN/AU/PS1090140
Metagenics Parex and Metagenics Costat
Official information organised for easier consultation. The source publication remains authoritative.
Identification
Product identification
- Product
- Metagenics Parex and Metagenics Costat
Official information
Risk and measures
- Risk or hazard
- The Therapeutic Goods Administration (TGA) has undertaken a review of the safety of the ingredient Artemisia, and has formed the view that the safety of listed medicines containing Artemisia species may pose a risk when used by consumers who are pregnant or likely to become pregnant. Medicines containing Artemisia may cause illness if taken by pregnant women or women who intend to become pregnant and may cause injury to unborn children.
- Recommendations
- Consumers should not take the products if they are pregnant, or likely to become pregnant. Consumers should return the product to their place of purchase for a full refund. Anyone who is concerned in any way about the use of this product should consult their doctor. For more information, consumers can contact Metagenics Customer Service by phone on 1800 777 648.
Official information
Economic operators
- Manufacturer
- Metagenics (Aust) Pty Ltd
Territory
Geography
- Distribution
- Retirada en Australia
- Country of recall
- Australia
Provenance and context
NagameAlert distinguishes content published by the source from its organisation and normalisation. Values marked “NagameAlert” belong to that processing layer. Always check measures, scope and updates in the official publication.